Vertex Pharmaceuticals | VRTX - Capitalização De Mercado





Capitalização De Mercado Alterar Data
AbbVie USD 508.97B 46.71B 2026-11
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
Arrowhead Research USD 11.5B 2.72B 2026-06
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Gilead Sciences USD 184.82B 27.96B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Insmed USD 24.93B 1.82B 2026-09
Ionis Pharmaceuticals USD 4.52B 2.9B 2026-11
J&J USD 653.61B 42.25B 2026-09
Merck USD 375.59B 17.09B 2026-11
Moderna USD 99.14B 22.26B 2026-11
Neurocrine Biosciences USD 16.38B 1.96B 2026-11
Novartis USD 292.09B 51.5B 2026-09
Pfizer USD 165.12B 1.71B 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 100.56B 13.53B 2026-11
Sarepta Therapeutics USD 1.65B 276M 2026-11
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
United Therapeutics USD 28.64B 5.4B 2026-11
Vertex Pharmaceuticals USD 140.44B 7.93B 2026-11